Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "tyrosine"

Research and Markets Adds Report: Tyrosine Kinase Inhibitors M...

Research and Markets has announced the addition of the "Tyrosine Kinase Inhibitors Market & Pipeline Insight 2015" report to its offerings. In a release, Research and Markets noted that report highlights include: Tyrosine kinase therapeutics ... Individual.com, 1 week ago
Test Your Cancer IQ Diabetes Care, 2 days ago
[x]  

66 images for tyrosine

Medical News Today, 1 week ago
OncLive, 6 days ago
Cellular Physiology and Biochemistry, 5 days ago
Cellular Physiology and Biochemistry, 5 days ago
Cellular Physiology and Biochemistry, 5 days ago
Karger.com, 6 days ago
Medical Xpress, 1 week ago
PR inside, 2 weeks ago
Global Information Inc, 2 weeks ago
European Hospital, 1 month ago

Threshold Pharmaceuticals Reports Preclinical Data Suggesting That TH-4000 May Overcome Resistance to Conventional EGFR Tyrosine Kinase Inhibitors

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 04/22/15 -- Threshold Pharmaceuticals, Inc. ( NASDAQ: THLD ) today announced preclinical data on TH-4000, its proprietary, molecularly-targeted, hypoxia-activated, irreversible epidermal growth factor ...
 Securities Technology Monitor4 days ago Threshold Pharma Offers Preclinical Data Suggesting TH-4000 Could Overcome Resistance to Conventional EGFR Tyrosin Kinase Inhibitors  Fat Pitch Financials4 days ago Threshold Pharmaceuticals, Inc. (THLD) Reports Preclinical Data Suggesting That TH-4000 May Overcome Resistance To Conventional EGFR Tyrosine Kinase Inhibitors 4/23/2015  ClinicSpace3 days ago Threshold Pharmaceuticals Updates on Analyst and Investor Day  Individual.com4 days ago
[x]  
European Pharmaceutical Review

Ariad presents updated clinical data on brigatinib in patients with ALK+ NSCLC

ARIAD Pharmaceuticals has announced updated clinical data on its investigational tyrosine kinase inhibitor, brigatinib (AP26113), in patients with anaplastic lymphoma kinase positive (ALK+) advanced non-small cell lung cancer (NSCLC) from an ongoing ...
 European Pharmaceutical Review4 days ago Ariad announces updated Phase I/II results on brigatinib  Pharma Letter1 week ago ARIAD Issues Updated Clinical Data on Brigatinib in Patients with ALK+ Non-Small Cell Lung Cancer  Individual.com4 days ago ARIAD Announces Results of Preclinical Studies on Brigatinib at the American Association for Cancer Research Annual Meeting  Market Pulse Navigator5 days ago
[x]  

Pazopanib plus paclitaxel may increase survival in platinum-resistant ovarian cancer

1. In patients with advanced, platinum-resistant ovarian cancer, combination therapy of a tyrosine kinase inhibitor, pazopanib, with paclitaxel significantly increased progression-free survival compared to paclitaxel alone. 2. Patients who ...
 2 Minute Medicine1 day ago

Structural and Biochemical Analysis of Tyrosine Phosphatase Related to Biofilm Formation A (TpbA) from the Opportunistic Pathogen Pseudomonas aeruginosa PAO1

by Kun Xu, Shanshan Li, Wen Yang, Kan Li, Yuwei Bai, Yueyang Xu, Jin Jin, Yingying Wang, Mark Bartlam Biofilms are important for cell communication and growth in most bacteria, and are responsible for a number of human clinical infections and ...
 Plosone.org2 days ago

ORIENTAL study terminated due to failure of TSU-68 in interim analysis

VIENNA — Clinicians stopped a trial of novel tyrosine kinase inhibitor TSU-68 in hepatocellular carcinoma after the drug failed to best placebo in overall survival in patients with hepatocellular carcinoma, according to findings presented at the ...
 Orthopedics Today3 days ago

Are Striatal Tyrosine Hydroxylase Interneurons Dopaminergic?

, Osvaldo Ibáñez-Sandoval , Tibor Koós , and James M. Tepper Center for Molecular and Behavioral Neuroscience, Rutgers University, Newark, New Jersey 07102 Author contributions: H.S.X., T.K., and J.M.T. designed research; H.S.X. and ...
 Journal of Neuroscience4 days ago

Evaluation of the effect of food and gastric pH on the single-dose pharmacokinetics of cabozantinib in healthy adult subjects

Abstract Cabozantinib is a small molecule tyrosine kinase inhibitor that has been approved for the treatment of patients with progressive, metastatic medullary thyroid cancer. Cabozantinib exhibits a pH-dependent solubility profile in vitro . Two ...
 Journal of Clinical Pharmacology4 days ago ARIAD Pharmaceuticals receives Health Canada approval for leukemia drug  Individual.com1 week ago

Thermodynamics by synchrotron X-ray Diffraction: Phase relationships and crystal structure of L-tyrosine ethyl ester form III

We welcome your comments for improvement of this site and our services. Comments Email ID Security Details ...
 RSC5 days ago

ROR2 receptor tyrosine kinase as a new target in cancer

Series Name: Cancer Genetics and Genomics Presenter: Dr. Santosh Gupta Sponsors: Duke Cancer Genetics and Genomics and Duke Cancer Institute Location: Fitzpatrick CIEMAS 2240 - Map When: 04/20/2015 at 01:00 PM to 04/20/2015 at ...
 Duke University1 week ago Genomic profiling of gastric cancer identifies drug-targetable mutations  Medical News Today6 days ago Prospective Comprehensive Genomic Profiling of Advanced Gastric Carcinoma Cases Reveals Frequent Clinically Relevant Genomic Alterations and New Routes for Targeted Therapies  The Oncologist1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less